These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12593353

  • 21. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [Abstract] [Full Text] [Related]

  • 22. First-trimester screening for Down's syndrome.
    Wald NJ.
    N Engl J Med; 2004 Feb 05; 350(6):619-21; author reply 619-21. PubMed ID: 14762194
    [No Abstract] [Full Text] [Related]

  • 23. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies.
    Garchet-Beaudron A, Dreux S, Leporrier N, Oury JF, Muller F, ABA Study Group, Clinical Study Group.
    Prenat Diagn; 2008 Dec 05; 28(12):1105-9. PubMed ID: 19003979
    [Abstract] [Full Text] [Related]

  • 24. Second trimester serum markers.
    Canick JA, MacRae AR.
    Semin Perinatol; 2005 Aug 05; 29(4):203-8. PubMed ID: 16104669
    [Abstract] [Full Text] [Related]

  • 25. Antenatal screening for Down syndrome.
    Wald NJ.
    Prog Clin Biol Res; 1995 Aug 05; 393():27-42. PubMed ID: 8545455
    [Abstract] [Full Text] [Related]

  • 26. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy.
    Miron P, Côté YP, Lambert J.
    Prenat Diagn; 2008 Mar 05; 28(3):180-5. PubMed ID: 18264956
    [Abstract] [Full Text] [Related]

  • 27. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Jul 05; 110(1):10-7. PubMed ID: 17601890
    [Abstract] [Full Text] [Related]

  • 28. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ, Morris JK, Ibison J, Wu T, George LM.
    Prenat Diagn; 2006 Jun 05; 26(6):559-64. PubMed ID: 16700087
    [Abstract] [Full Text] [Related]

  • 29. Three-stage contingent screening for Down syndrome.
    Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P.
    Prenat Diagn; 2006 Jun 05; 26(6):528-34. PubMed ID: 16634118
    [Abstract] [Full Text] [Related]

  • 30. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM, Halliday JL, Francis I, Bonacquisto L, Forbes R, Cronin A, Sheffield LJ.
    BJOG; 2007 Jul 05; 114(7):812-8. PubMed ID: 17501960
    [Abstract] [Full Text] [Related]

  • 31. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN, Canick JA.
    Clin Obstet Gynecol; 2008 Mar 05; 51(1):24-36. PubMed ID: 18303497
    [Abstract] [Full Text] [Related]

  • 32. A summary analysis of Down syndrome markers in the late first trimester.
    Palomaki GE, Lambert-Messerlian GM, Canick JA.
    Adv Clin Chem; 2007 Mar 05; 43():177-210. PubMed ID: 17249384
    [Abstract] [Full Text] [Related]

  • 33. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W, Rudnicka A, Wald NJ.
    Prenat Diagn; 2004 Oct 05; 24(10):804-7. PubMed ID: 15503275
    [Abstract] [Full Text] [Related]

  • 34. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov 05; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 35. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
    Wald NJ, Barnes IM, Birger R, Huttly W.
    Prenat Diagn; 2006 Jun 05; 26(6):539-44. PubMed ID: 16634123
    [Abstract] [Full Text] [Related]

  • 36. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
    Weisz B, Rodeck CH.
    Hum Reprod Update; 2006 Jun 05; 12(5):513-8. PubMed ID: 16672245
    [Abstract] [Full Text] [Related]

  • 37. Women as moral pioneers? Experiences of first trimester antenatal screening.
    Williams C, Sandall J, Lewando-Hundt G, Heyman B, Spencer K, Grellier R.
    Soc Sci Med; 2005 Nov 05; 61(9):1983-92. PubMed ID: 15899542
    [Abstract] [Full Text] [Related]

  • 38. Biochemical screening for congenital defects.
    Bahado-Singh RO, Sutton-Riley J.
    Obstet Gynecol Clin North Am; 2004 Dec 05; 31(4):857-72, xi. PubMed ID: 15550339
    [Abstract] [Full Text] [Related]

  • 39. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan 05; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 40. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 05; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.